Proteomic analysis of central nervous system inflammation in multiple sclerosis.

该项目旨在确定多发性硬化症(MS)的新治疗目标和诊断方法，多发性硬化症是年轻人最常见的神经系统疾病。据估计，这种疾病在澳大利亚每年造成的经济负担约为20亿美元。此外，还有很大的社会成本需要考虑。尽管进行了大量研究，但目前的治疗方法有限。我们预计，这项研究将：产生新的治疗方法和更好的诊断方法，从而减少这种疾病的经济和人力成本；产生具有后续经济效益的知识产权；扩大蛋白质组学技术，使其对包括经济效益和效益在内的广泛基础研究产生影响。

This project aims to identify new therapeutic targets and diagnostics for Multiple Sclerosis (MS) the most common neurological disease in young adults. The estimated economic burden of this disease in Australia is around $2 billion per annum. There is also a large social cost to take into account. In spite of a great deal of research, current therapies are limited. We expect that this this research will: lead to new therapies and better diagnostics, which will reduce the financial and human cost of this disease; generate IP with subsequent economic benefits and; expand proteomics technologies which will have flow on effects including economic benefits and benefits to a wide range of basic research.